Company / News

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)

Guidance for Industry and Food and Drug Administration Staff

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.

download whitepaper

Related News

Voler Systems’ Universal Health-Sensor Platform Jumpstarts...

June 26, 2018 - Sunnyvale CA, Voler Systems is excited...

Best wireless standard for your application?

There are now many competing wireless standards, each with its...

Wake-Up Circuits

Accelerometers are widely used in electronic products such as phones,...

Newsletter Sign Up
chat-icon
clse-1
Get Expert Consulting

Voler is really good at identifying risks and finding the best way to do a project on-time, on spec, and easy to manufacture.